Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive Enrichment Designed, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of Anshen Buxin Liuwei Pills in the Treatment of Cardiac Neurosis

NCT04932395 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT04932395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive Enrichment Designed, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of Anshen Buxin Liuwei Pills in the Treatment of Cardiac Neurosis
Lead sponsor
China Academy of Chinese Medical Sciences
Phase
Phase 4
Overall status
Unknown status
Start date
June 22, 2021
Completion date
June 1, 2024
Enrollment
400 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac neurosis